Atherogenic lipid profile of Brazilian near-term newborns

Cardiovascular disease is the primary cause of death in Brazil. Recent studies have shown that low birth weight and preterm birth are linked to a higher prevalence of cardiovascular disease. The aim of the present study was to compare the levels of lipids and apolipoproteins and atherogenic indexes between term and near-term newborn infants. A sample of umbilical cord blood was obtained from 135 newborns (66 males) divided into two groups: 25 near-term neonates (35-36.6 weeks of gestational age) and 110 term neonates (37-42 weeks of gestational age). The total cholesterol concentrations were higher in the near-term neonates than in the term group (94.04 ± 8.02 vs 70.42 ± 1.63 mg/dl, P < 0.01), due to an increase in the LDL-cholesterol fraction in the near-term group (57.76 ± 6.39 vs 34.38 ± 1.29 mg/dl, P < 0.001). The atherogenic indexes (total cholesterol/HDL-cholesterol, LDL-cholesterol/HDL-cholesterol and apolipoprotein B/apolipoprotein A-I) were higher in the near-term group (P < 0.001, P < 0.001, and P < 0.05, respectively). The gestational age of the newborns was inversely correlated with total cholesterol and LDL-cholesterol, and also with the total cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol indexes. These findings demonstrate that the lipid profile is worse in the group of near-term neonates compared with the term group. Future studies are needed to determine if this atherogenic profile in near-term neonates can affect body metabolism, increasing the risk for cardiovascular diseases in adult life.75576

Effect of biliopancreatic diversion on sleep quality and daytime sleepiness in patients with obesity and type 2 diabetes

sem informaçãoThe poor quality of sleep and the deprivation thereof have been associated with disruption of metabolic homeostasis, favoring the development of obesity and type 2 diabetes (T2DM). We aimed to evaluate the influence of biliopancreatic diversion (BPD) surg616623627sem informaçãosem informaçãosem informaçã

Atherogenic Lipid Profile Of Brazilian Near-term Newborns.

Cardiovascular disease is the primary cause of death in Brazil. Recent studies have shown that low birth weight and preterm birth are linked to a higher prevalence of cardiovascular disease. The aim of the present study was to compare the levels of lipids and apolipoproteins and atherogenic indexes between term and near-term newborn infants. A sample of umbilical cord blood was obtained from 135 newborns (66 males) divided into two groups: 25 near-term neonates (35-36.6 weeks of gestational age) and 110 term neonates (37-42 weeks of gestational age). The total cholesterol concentrations were higher in the near-term neonates than in the term group (94.04 +/- 8.02 vs 70.42 +/- 1.63 mg/dl, P < 0.01), due to an increase in the LDL-cholesterol fraction in the near-term group (57.76 +/- 6.39 vs 34.38 +/- 1.29 mg/dl, P < 0.001). The atherogenic indexes (total cholesterol/HDL-cholesterol, LDL-cholesterol/HDL-cholesterol and apolipoprotein B/apolipoprotein A-I) were higher in the near-term group (P < 0.001, P < 0.001, and P < 0.05, respectively). The gestational age of the newborns was inversely correlated with total cholesterol and LDL-cholesterol, and also with the total cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol indexes. These findings demonstrate that the lipid profile is worse in the group of near-term neonates compared with the term group. Future studies are needed to determine if this atherogenic profile in near-term neonates can affect body metabolism, increasing the risk for cardiovascular diseases in adult life.38755-6

Leptin As A Marker Of Sexual Dimorphism In Newborn Infants

Objective: To determine cord blood leptin levels in newborns appropriate for gestational age, according to gender, birth weight, birth height and ponderal index. Methods: A cross-sectional study was carried out with 132 term newborns appropriate for gestational age (68 females, 64 males), gestational age between 35-42 weeks. Data were collected through interviews with the mothers at the maternity, anthropometrycal study of the newborns, and cord blood estradiol, testosterone and leptin assays obtained immediately after birth. Results: The levels of leptin were significantly higher in females than in males (8.34±0.65 ng/ml versus 6.06±0.71 ng/ml; p = 0.000). The concentrations of estradiol and testosterone did not differ between males and females. Leptin levels were positively correlated with gestational age (r = 0.394, p < 0.01), birth weight (r = 0.466, p < 0.01), birth length (r = 0.335, p < 0.01) and ponderal index (r = 0.326, p < 0.01). Conclusions: Leptin concentration in the umbilical cord is positively correlated with gestational age, birth weight, birth height, and ponderal index, suggesting its participation in the neonatal growth process. In addition, a gender difference with higher levels of leptin in females neonates was observed, suggesting that the sexual dimorphism in relation to body composition already exists in newborns. Copyright © 2004 by Sociedade Brasileira de Pediatria.804305308Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J., Positional cloning of the mouse obese gene and its human homologue (1994) Nature, 372, pp. 425-432Seeley, R.J., Schwartz, M.W., Neuroendocrine regulation of food intake (1999) Acta Paediatr Suppl, 88 (428), pp. 58-61Cunningham, M.J., Clifton, D.K., Steiner, R.A., Leptini's actions on the reproductive axis: Perspectives and mechanisms (1999) Biol Reprod, 60, pp. 216-222Koistinen, H.A., Koivisto, V.A., Kontula, K., Andersson, S., Teramo, K.A., Leptin concentration in cord blood correlates with intrauterine growth (1997) J Clin Endocrinol Metab, 82, pp. 3328-3330Schubring, C., Kiess, W., Englaro, P., Rascher, W., Dotsch, J., Blum, W., Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: Relation to neonatal and placental weight (1997) J Clin Endocrinol Metab, 82, pp. 1480-1483Tarquini, B., Tarquini, R., Perfetto, F., Cornelissen, G., Halberg, F., Genetic and environmental influences on human cord blood leptin concentration (1999) Pediatrics, 103, pp. 998-1006Alexander, G.R., Himes, J.H., Kaufman, R.B., Mor, J., Kogan, M., A United States National Reference for fetal growth (1996) Obstet Gynecol, 87, pp. 163-168Monte, O., Longui, C.A., Calliari, L.E.P., (1998) Endocrinologia Pediátrica, , São Paulo: Editora AtheneuVan Den Brandle, J.L., Somatomedins on the move (1990) Horm Res, 33, pp. 58-68Gómez, L., Carrascosa, A., Yeste, D., Potau, N., Riqué, S., Almar, J., Leptin values in placental cord blood of human newborns with normal intrauterine growth after 30-42 weeks of gestation (1999) Horm Res, 51, pp. 10-14Vatten, L.J., Nilsen, S.T., Odegård, R.A., Romundstad, P.R., Austgulen, R., Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term (2002) Pediatrics, 109, pp. 1131-1135Hassink, S.G., Lancey, E., Sheslow, D.V., Considine, R.V., Dostal, K., Smith-Kirwin, S.M., Placental leptin: Important new growth factor in intrauterine and neonatal development? (1997) Pediatrics, 100, pp. E1Tamura, T., Goldenberg, R.L., Johnston, K.E., Cliver, S.P., Serum leptin concentrations during pregnancy and their relationship to fetal growth (1998) Obstet Gynecol, 91, pp. 389-395Schubring, C., Englaro, P., Siebler, T., Blum, W.F., Demirakca, T., Kiess, W., Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth: Relation to body mass index, skinfolds, sex steroids and umbilical blood leptin levels (1998) Horm Res, 50, pp. 276-283Matsuda, J., Yokota, I., Iiida, M., Murakami, T., Naito, E., Ito, M., Serum leptin concentration in cord blood: Relationship to birth weight and gender (1997) J Clin Endocrinol Metab, 82, pp. 1642-1644Helland, I.B., Reseland, J.E., Saugstad, O.D., Drevon, C.A., Leptin levels in pregnant women and newborn infants: Gender differences and reduction during the neonatal period (1998) Pediatrics, 101, pp. E12Geary, M., Pringle, P.J., Persaud, M., Wilshin, J., Hindmarsh, P.C., Rodeck, C.H., Leptin concentrations in maternal serum and cord blood: Relationship to maternal anthropometry and fetal growth (1999) Br J Obstet Gynaecol, 106, pp. 1054-1060Schulz, S., Häckel, C., Weise, W., Hormonal regulation of neonatal weight: Placental leptin and leptin receptors (2000) BJOG, 107, pp. 1486-1491Lepercq, J., Lahlou, N., Timsit, J., Girard, J., Mouzon, S.H., Macrosomia revisited: Ponderal index and leptin delineate subtypes of fetal overgrowth (1999) Am J Obstet Gynecol, 181, pp. 621-625Papadopoulou, F.G., Mamopoulos, A.M., Triantos, A., Constantinidis, T.C., Papadimas, J., Assimakopoulos, E.A., Leptin levels in maternal and cord serum: Relationship with fetal development and placental weight (2000) J Matern Fetal Med, 9, pp. 298-302Ogueh, O., Sooranna, S., Nicolaides, K.H., Johnson, M.R., The relationship between leptin concentration and bone metabolism in the human fetus (2000) J Clin Endocrinol Metab, 85, pp. 1997-1999Christou, H., Connors, J.M., Ziotopoulou, M., Hatzidakis, V., Papathanassoglou, E., Ringer, S.A., Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth (2001) J Clin Endocrinol Metab, 86, pp. 935-938Su, P.H., Wang, S.L., Chen, J.Y., Lai, C.P., Jian, S.H., Serum leptin levels in preterm, healthy and sick-term newborns (2002) Acta Paediatr, 43, pp. 249-254. , TaiwanYang, M.J., Liu, R.S., Hung, J.H., Leptin concentrations in the umbilical vein and artery. Relationship to maternal and neonatal anthropometry (2002) J Reprod Med, 47, pp. 645-650Ong, K.K., Ahmed, M.L., Sherriff, A., Woods, K.A., Watts, A., Golding, J., Cord blood leptin is associated with size at birth and predicts infancy weight gain in humans (1999) J Clin Endocrinol Metab, 84, pp. 1145-1148Copper, R.L., Goldenberg, R.L., Cliver, S.P., Dubard, M.B., Hoffman, H.J., Davis, R.O., Anthropometric assessment of body size differences of full-term male and female infants (1993) Obstet Gynecol, 81, pp. 161-16

Atherogenic lipid profile of Brazilian near-term newborns

Abstract Cardiovascular disease is the primary cause of death in Brazil. Recent studies have shown that low birth weight and preterm birth are linked to a higher prevalence of cardiovascular disease. The aim of the present study was to compare the levels of lipids and apolipoproteins and atherogenic indexes between term and near-term newborn infants. A sample of umbilical cord blood was obtained from 135 newborns (66 males) divided into two groups: 25 near-term neonates (35-36.6 weeks of gestational age) and 110 term neonates (37-42 weeks of gestational age). The total cholesterol concentrations were higher in the near-term neonates than in the term group (94.04 ± 8.02 vs 70.42 ± 1.63 mg/dl, P &lt; 0.01), due to an increase in the LDL-cholesterol fraction in the near-term group (57.76 ± 6.39 vs 34.38 ± 1.29 mg/dl, P &lt; 0.001). The atherogenic indexes (total cholesterol/HDL-cholesterol, LDL-cholesterol/HDL-cholesterol and apolipoprotein B/apolipoprotein A-I) were higher in the near-term group (P &lt; 0.001, P &lt; 0.001, and P &lt; 0.05, respectively). The gestational age of the newborns was inversely correlated with total cholesterol and LDL-cholesterol, and also with the total cholesterol/HDL-cholesterol and LDL-cholesterol/ HDL-cholesterol indexes. These findings demonstrate that the lipid profile is worse in the group of near-term neonates compared with the term group. Future studies are needed to determine if this atherogenic profile in near-term neonates can affect body metabolism, increasing the risk for cardiovascular diseases in adult life. Correspondenc

Rosiglitazone decreases intra- to extramyocellular fat ratio in obese non-diabetic adults with metabolic syndrome

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Background Insulin resistance is intrinsically related to intramyocellular (IMCL) rather than extramyocellular (EMCL) triglyceride content. Conflicting results have been reported on the ability of insulin sensitizer agents, such as thiazolidinediones, to modify muscle fat distribution. The aim of this study was to investigate the role of rosiglitazone on muscle fat compartment distribution in an adult population of obese non-diabetic metabolic syndrome patients. Patients and methods Fifteen obese, non-diabetic, metabolic syndrome patients were studied by means of proton nuclear magnetic resonance ((1)H-NMR) spectroscopy before and after treatment with rosiglitazone 8 mg/day for 6 months. Anthropometrical and metabolic variables were assessed. Results After rosiglitazone, body weight and hip circumference increased [100.9 (91.12-138.7) vs. 107.0 (79.6-142.8) kg and 118 (107-126) vs. 122 (110-131) cm]; while waist-hip ratio (WHR) decreased from 0.93 (0.87-1.00) to 0.89 (0.82-0.97) (P < 0.001 for all). Additionally, fasting plasma glucose, insulin and homeostatis model assessment of insulin resistance (HOMA-IR) significantly decreased while adiponectin increased over threefold [9.7 (3.7-17.7) vs. 38.0 (19.3-42.4) mu g/ml] without any changes in resistin. Finally, the IMCL did not change [267.54 (213.94-297.94) vs. 305.75 (230.80-424.75) arbitrary units (AU), P = 0.15] while the EMCL increased [275.53 (210.39-436.66) vs. 411.39 (279.92-556.59) AU; P < 0.01] therefore decreasing the IMCL-to-EMCL (IMCL/EMCL) ratio [1.07 (0.78-1.23) vs. 0.71 (0.53-0.96); P < 0.01]. Conclusion Rosiglitazone treatment increased body weight and hip circumference and decreased WHR. More importantly, it decreased the IMCL/EMCL ratio by increasing the EMCL without any significant change on the IMCL.2712329Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Research Supporting Agency of Rio de Janeiro State [E-26/150.141/99, E-26/170.522/00]Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)CNPq [CNPq 52 1850/96-7]Research Supporting Agency of Rio de Janeiro State [E-26/150.141/99, E-26/170.522/00

Polymorphism In Lep And Lepr May Modify Leptin Levels And Represent Risk Factors For Thyroid Cancer

Purpose. To understand the role of polymorphisms in the LEP (rs7799039 and rs2167270) and LEPR (rs1137101 and rs1137100) genes in DTC susceptibility and their effect on leptin levels. Methods. We studied 153 patients with DTC and 234 controls through TaqMan SNP Genotyping and ELISA, comparing these data to the clinicopathological data of patients with DTC. Results. Patients with AA genotype of rs7799039 had higher levels of serum leptin (9.22 ± 0.98 ng/mL) than those with AG genotype (10.07 ± 0.60 ng/mL; P = 0.005). Individuals with AG genotype of rs2167270 also produced higher serum leptin levels (10.05 ± 0.59 ng/mL) than the subjects with GG genotype (9.52 ± 0.79 ng/mL; P A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis (2011) Clinical and Experimental Rheumatology, 29 (2), pp. 293-298Jiang, Y., Wilk, J.B., Borecki, I., Common variants in the 5' region of the leptin gene are associated with bodymass index in men fromthe National Heart, Lung, and Blood Institute Family Heart Study (2004) The American Journal of Human Genetics, 75 (2), pp. 220-230He, J., Xi, B., Ruiter, R., Association of LEP G2548A and LEPR Q223R polymorphisms with cancer susceptibility: Evidence froma meta-analysis (2013) PLoS ONE, 8 (10)Furusawa, T., Naka, I., Yamauchi, T., The Q223R polymorphism in LEPR is associated with obesity in Pacific Islanders (2010) Human Genetics, 127 (3), pp. 287-294Saukko, M., Kesäniemi, Y.A., Ukkola, O., Leptin receptor Lys109Arg and Gln223Arg polymorphisms are associated with early atherosclerosis (2010) Metabolic Syndrome and Related Disorders, 8 (5), pp. 425-430Lucas, A., Granada, M.L., Olaizola, I., Leptin and thyrotropin relationship is modulated by smoking status in euthyroid subjects (2013) Thyroid, 23 (8), pp. 964-970Duntas, L.H., Biondi, B., The interconnections between obesity, thyroid function, and autoimmunity: Themultifold role of leptin (2013) Thyroid, 23 (6), pp. 646-653Marzullo, P., Minocci, A., Tagliaferri, M.A., Investigations of thyroid hormones and antibodies in obesity: Leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants (2010) Journal of Clinical Endocrinology and Metabolism, 95 (8), pp. 3965-3972Guzel, S., Seven, A., Guzel, E.C., Buyuk, B., Celebi, A., Aydemir, B., Visfatin, leptin, and TNF-α: Interrelated adipokines in insulin-resistant clinical and subclinical hypothyroidism (2013) Endocrine Research, 38 (3), pp. 184-194Mammès, O., Betoulle, D., Aubert, R., Herbeth, B., Siest, G., Fumeron, F., Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight (2000) Annals of Human Genetics, 64 (5), pp. 391-394Portoles, O., Sorli, J.V., Frances, F., Effect of genetic variation in the leptin gene promoter and the leptin receptor gene on obesity risk in a population-based case-control study in Spain (2006) European Journal of Epidemiology, 21 (8), pp. 605-612Liu, C., Liu, L., Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: A metaanalysis (2011) Tumour Biology, 32 (6), pp. 1233-1240Hoffsted, J., Eriksson, P., Mottagui-Tabar, S., Arner, P., A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin (2002) Hormone and Metabolic Research, 34 (7), pp. 355-359Murugesan, D., Arunachalam, T., Ramamurthy, V., Subramanian, S., Association of polymorphisms in leptin receptor gene with obesity and type 2 diabetes in the local population of Coimbatore (2010) Indian Journal of Human Genetics, 16 (2), pp. 72-77Quinton, N.D., Lee, A.J., Ross, R.J.M., Eastell, R., Blakemore, A.I.F., A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fatmass and leptin levels in postmenopausal Caucasian women (2001) Human Genetics, 108 (3), pp. 233-236Mattevi, V.S., Zembrzuski, V.M., Hutz, M.H., Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil (2002) International Journal of Obesity, 26 (9), pp. 1179-1185Yiannakouris, N., Yannakoulia, M., Melistas, L., Chan, J.L., Klimis-Zacas, D., Mantzoros, C.S., TheQ223Rpolymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of bodyweight and body composition variability (2001) Journal of Clinical Endocrinology and Metabolism, 86 (9), pp. 4434-4439Stefan, N., Vozarova, B., Del Parigi, A., The Gln223Arg polymorphism of the leptin receptor in Pima Indians: Influence on energy expenditure, physical activity and lipid metabolism (2002) International Journal of Obesity, 26 (12), pp. 1629-1632Chiu, K.C., Chu, A., Chuang, L.-M., Saad, M.F., Association of leptin receptor polymorphism with insulin resistance (2004) European Journal of Endocrinology, 150 (5), pp. 725-729Chu, A., Chuang, L.M., Saad, M., Chiu, K., Association of the Q223R polymorphism of the leptin receptor gene with insulin resistance and metabolic syndrome (2003) Diabetes, 52, p. A510Pimentel Duarte, S.F., Francischetti, E.A., Genelhu-Abreu, V., P. Q223R leptin receptor polymorphism associated with obesity in Brazilianmultiethnic subjects (2006) The American Journal of Human Biology, 18 (4), pp. 448-453Wauters, M., Mertens, I., Chagnon, M., Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women (2001) International Journal of Obesity, 25 (5), pp. 714-720Ogawa, T., Hirose, H., Yamamoto, Y., Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population (2004) Metabolism: Clinical and Experimental, 53 (7), pp. 879-885Fairbrother, U.L., Tankó, L.B., Walley, A.J., Christiansen, C., Froguel, P., Blakemore, A.I.F., Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women (2007) Journal of Bone and Mineral Research, 22 (4), pp. 544-550Salopuro, T., Pulkkinen, L., Lindström, J., Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study (2005) International Journal of Obesity, 29 (10), pp. 1245-1251Wauters, M., Mertens, I., Rankinen, T., Chagnon, M., Bouchardt, C., Van Gaal, L., Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance (2001) Journal of Clinical Endocrinology and Metabolism, 86 (7), pp. 3227-3232Park, K.S., Shin, H.D., Park, B.L., Polymorphisms in the leptin receptor (LEPR)-putative association with obesity and T2DM (2006) Journal of Human Genetics, 51 (2), pp. 85-91Han, C.-Z., Du, L.-L., Jing, J.-X., Associations among lipids, leptin, and leptin receptor geneGin223Arg polymorphisms and breast cancer in China (2008) Biological Trace Element Research, 126 (1-3), pp. 38-48Okobia, M.N., Bunker, C.H., Garte, S.J., Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: A case control study (2008) BMC Cancer, 8He, B.-S., Pan, Y.-Q., Zhang, Y., Xu, Y.-Q., Wang, S.-K., Effect of LEPR Gln223Arg polymorphism on breast cancer risk in different ethnic populations: A meta-analysis (2012) Molecular Biology Reports, 39 (3), pp. 3117-3122Lin, D.W., Fitz Gerald, L.M., Fu, R., Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality (2011) Cancer Epidemiology, Biomarkers & Prevention, 20 (9), pp. 1928-1936Li, Y.L., Geng, J.L., Wang, Y., The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients (2012) Journal of Cancer Research and Clinical Oncology, 138 (2), pp. 311-316Wazir, U., Al Sarakbi, W., Jiang, W.G., Mokbel, K., Evidence of an autocrine role for leptin and leptin receptor in human breast cancer (2012) CancerGenomics and Proteomics, 9 (6), pp. 383-388Li, L., Lee, K.J., Choi, B.C., Baek, K.H., Relationshipbetween leptin receptor and polycystic ovary syndrome (2013) Gene, 527 (1), pp. 71-74Friedlander, Y., Li, G., Fornage, M., Candidate molecular pathway genes related to appetite regulatory neural network, adipocyte homeostasis and obesity: Results from the CARDIA Study (2010) Annals of Human Genetics, 74 (5), pp. 387-39